Aperio Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $3.39M | Buy |
19,903
+1,940
| +11% | +$331K | 0.01% | 1001 |
|
|
2020
Q3 | $2.52M | Buy |
17,963
+1,151
| +7% | +$162K | 0.01% | 1013 |
|
|
2020
Q2 | $2.7M | Buy |
16,812
+2,081
| +14% | +$334K | 0.01% | 972 |
|
|
2020
Q1 | $1.44M | Buy |
14,731
+4,720
| +47% | +$462K | 0.01% | 1160 |
|
|
2019
Q4 | $1.29M | Sell |
10,011
-1,027
| -9% | -$132K | ﹤0.01% | 1302 |
|
|
2019
Q3 | $832K | Sell |
11,038
-1,003
| -8% | -$75.6K | ﹤0.01% | 1490 |
|
|
2019
Q2 | $1.83M | Buy |
12,041
+3,414
| +40% | +$519K | 0.01% | 1103 |
|
|
2019
Q1 | $1.03M | Sell |
8,627
-3,833
| -31% | -$457K | ﹤0.01% | 1356 |
|
|
2018
Q4 | $1.36M | Buy |
12,460
+4,866
| +64% | +$531K | 0.01% | 1148 |
|
|
2018
Q3 | $1.23M | Buy |
7,594
+2,672
| +54% | +$432K | 0.01% | 1291 |
|
|
2018
Q2 | $651K | Buy |
4,922
+1,561
| +46% | +$206K | ﹤0.01% | 1629 |
|
|
2018
Q1 | $249K | Sell |
3,361
-575
| -15% | -$42.6K | ﹤0.01% | 2040 |
|
|
2017
Q4 | $219K | Buy |
+3,936
| New | +$219K | ﹤0.01% | 2112 |
|